\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ resection\\ was\\ curative\ \(0\)\
\-\ ct\ \(23117\)\
\-\ \\ 3\\-cm\\,\\ soft\\ tissue\\ density\\ mass\\ within\\ the\\ left\\ inferior\\ meatus\\ with\\ extension\\ into\\ the\\ left\\ nasal\\ passage\\.\ \(1\)\
\-\ \\ \ \(1082074\)\
\-\ scattered\\ areas\\ of\\ calcification\\ with\\ remodeling\\ of\\ the\\ bone\\.\ \(0\)\
\-\ no\\ definite\\ osseous\\ destruction\\.\ \(0\)\
\-\ mild\\ mucoperiosteal\\ thickening\\ of\\ the\\ bilateral\\ maxillary\\ and\\ frontal\\ sinuses\\,\\ as\\ well\\ as\\ the\\ ethmoidal\\ air\\ cells\\.\\ \ \(0\)\
\-\ mr\ \(14\)\
\-\ complex\\ mass\\ with\\ heterogeneous\\ signal\\ characteristics\\ and\\ heterogeneous\\ enhancement\\ characteristics\\ in\\ the\\ left\\ nasal\\ passage\\.\\ \ \(0\)\
\-\ interface\\ with\\ the\\ left\\ nasal\\ lacrimal\\ duct\\ and\\ superior\\ most\\ aspect\\ of\\ the\\ left\\ incisors\\.\\ \ \(0\)\
\-\ modeling\\ of\\ the\\ surrounding\\ osseous\\ structures\\ without\\ evidence\\ of\\ destruction\\ or\\ infiltration\\.\ \(0\)\
\-\ pleomorphic\\ adenoma\ \(4\)\
\-\ nasal\\ vault\\ masses\\ \\(non\\-aggressive\\)\ \(0\)\
\-\ sinonasal\\ polyp\ \(0\)\
\-\ inverted\\ papilloma\ \(0\)\
\-\ pleomorphic\\ adenoma\ \(4\)\
\-\ hemangioma\\ \\(epistaxis\\)\ \(0\)\
\-\ pyogenic\\ granuloma\\ \\(pedunculated\\ lobular\\ mass\\)\ \(0\)\
\-\ granuloma\\ gravidarum\\ \\(hemangioma\\ of\\ pregnancy\\)\\ in\\ women\ \(0\)\
\-\ hemangiopericytoma\ \(13\)\
\-\ juvenile\\ nasopharyngeal\\ angiofibroma\ \(0\)\
\-\ ectopic\\ salivary\\ gland\ \(0\)\
\-\ 44\\ y\\.o\\.\\ man\\ presents\\ with\\ blockage\\ of\\ the\\ left\\ nasal\\ airway\\.\ \(1\)\
\-\ although\\ pleomorphic\\ adenomas\\ are\\ most\\ commonly\\ associated\\ with\\ the\\ parotid\\ and\\ other\\ salivary\\ glands\\,\\ a\\ number\\ of\\ intranasal\\ pleomorphic\\ adeomas\\ have\\ been\\ reported\\ and\\ commonly\\ occur\\ between\\ 30\\ and\\ 50\\ yrs\\ of\\ age\\.\\ \\ as\\ in\\ this\\ patient\\,\\ the\\ common\\ presentation\\ involves\\ nasal\\ obstruction\\.\\ \\ in\\ contrast\\,\\ a\\ report\\ of\\ epistaxis\\ is\\ also\\ common\\.\ \(0\)\
\-\ on\\ direct\\ visualization\\ this\\ adenoma\\ was\\ typical\\ for\\ a\\ pleomorphic\\ adenoma\\ and\\ described\\ as\\ a\\ smooth\\,\\ glistening\\ gray\\ mass\\.\ \(0\)\
\-\ malignant\\ tumors\\ should\\ also\\ be\\ considered\\ in\\ the\\ differential\\ including\\ cartilaginous\\ tumors\\ from\\ the\\ nasal\\ septum\\ \\(although\\ this\\ mass\\ appeared\\ to\\ originate\\ from\\ the\\ inferior\\ nasal\\ turbinate\\)\\,\\ squamous\\ cell\\ carcinoma\\ and\\ adenocarinoma\\.\\ \\ exicsional\\ biopsy\\ is\\ diagnostic\\ and\\ therapeutic\ \(0\)\
\-\ motoori\\,\\ k\\.\\ ajnr\\ 2000\\;\\ 21\\:\\ 1948\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ nasal\\:\\ 0\\.43909013764030985\ \(0\)\
\-\ pleomorphic\\:\\ 0\\.30461926610076445\ \(0\)\
\-\ adenoma\\:\\ 0\\.1919892463943819\ \(0\)\
\-\ the\\:\\ 0\\.18019178131425104\ \(0\)\
\-\ epistaxis\\:\\ 0\\.15002675568883875\ \(0\)\
\-\ salivary\\:\\ 0\\.14194259919857644\ \(0\)\
\-\ passage\\:\\ 0\\.13275395532821865\ \(0\)\
\-\ of\\:\\ 0\\.1295972049198522\ \(0\)\
\-\ left\\:\\ 0\\.12322041997357171\ \(0\)\
\-\ mass\\:\\ 0\\.11498070399013201\ \(0\)\
\-\ and\\:\\ 0\\.11196289914083228\ \(0\)\
\-\ characteristics\\:\\ 0\\.11040900127799125\ \(0\)\
\-\ destruction\\:\\ 0\\.10977253441007746\ \(0\)\
\-\ granuloma\\:\\ 0\\.10895270766753953\ \(0\)\
\-\ hemangioma\\:\\ 0\\.10128380165495486\ \(0\)\
\-\ as\\:\\ 0\\.09674357642170749\ \(0\)\
\-\ gravidarum\\:\\ 0\\.09627854866029482\ \(0\)\
\-\ adeomas\\:\\ 0\\.09627854866029482\ \(0\)\
\-\ exicsional\\:\\ 0\\.09627854866029482\ \(0\)\
\-\ motoori\\:\\ 0\\.09627854866029482\ \(0\)\
\-\ 1948\\:\\ 0\\.09627854866029482\ \(0\)\
\-\ osseous\\:\\ 0\\.09610370811797392\ \(0\)\
\-\ incisors\\:\\ 0\\.09199929318452656\ \(0\)\
\-\ intranasal\\:\\ 0\\.09199929318452656\ \(0\)\
\-\ commonly\\:\\ 0\\.08909544294324517\ \(0\)\
\-\ glistening\\:\\ 0\\.08896311310589142\ \(0\)\
\-\ turbinate\\:\\ 0\\.08896311310589142\ \(0\)\
\-\ tumors\\:\\ 0\\.08855319221966729\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.08714794551485072\ \(0\)\
\-\ adenocarinoma\\:\\ 0\\.08660806887459106\ \(0\)\
\-\ mucoperiosteal\\:\\ 0\\.08468385763012315\ \(0\)\
\-\ although\\:\\ 0\\.08197081807862017\ \(0\)\
\-\ inferior\\:\\ 0\\.08191490311826036\ \(0\)\
\-\ meatus\\:\\ 0\\.08164767755148801\ \(0\)\
\-\ ethmoidal\\:\\ 0\\.07828673515369163\ \(0\)\
\-\ originate\\:\\ 0\\.07574152464964523\ \(0\)\
\-\ vault\\:\\ 0\\.07501337784441937\ \(0\)\
\-\ angiofibroma\\:\\ 0\\.07501337784441937\ \(0\)\
\-\ blockage\\:\\ 0\\.07501337784441937\ \(0\)\
\-\ in\\:\\ 0\\.0748834203815313\ \(0\)\
\-\ ajnr\\:\\ 0\\.07369241321851273\ \(0\)\
\-\ nasopharyngeal\\:\\ 0\\.07251854425032457\ \(0\)\
\-\ lacrimal\\:\\ 0\\.07146226917387695\ \(0\)\
\-\ parotid\\:\\ 0\\.07146226917387695\ \(0\)\
\-\ with\\:\\ 0\\.07073162139213299\ \(0\)\
\-\ curative\\:\\ 0\\.07050215824881215\ \(0\)\
\-\ adenomas\\:\\ 0\\.07005298652131633\ \(0\)\
\-\ common\\:\\ 0\\.06828459302591078\ \(0\)\
\-\ cartilaginous\\:\\ 0\\.06805573732032595\ \(0\)\
\-\ pedunculated\\:\\ 0\\.06735188038219991\ \(0\)\
\-\ remodeling\\:\\ 0\\.0670168064426812\ \(0\)\
\-\ yrs\\:\\ 0\\.0670168064426812\ \(0\)\
\-\ glands\\:\\ 0\\.06389849410054442\ \(0\)\
\-\ most\\:\\ 0\\.06266347871903373\ \(0\)\
\-\ this\\:\\ 0\\.062061049864376244\ \(0\)\
\-\ polyp\\:\\ 0\\.06130081981358444\ \(0\)\
\-\ lobular\\:\\ 0\\.06111065354083841\ \(0\)\
\-\ therapeutic\\:\\ 0\\.060923853220152896\ \(0\)\
\-\ airway\\:\\ 0\\.06038250673561256\ \(0\)\
\-\ 2000\\:\\ 0\\.060208057431662895\ \(0\)\
\-\ maxillary\\:\\ 0\\.05970137088827779\ \(0\)\
\-\ appeared\\:\\ 0\\.05953774059357519\ \(0\)\
\-\ infiltration\\:\\ 0\\.05937660856911653\ \(0\)\
\-\ definite\\:\\ 0\\.059217899674641264\ \(0\)\
\-\ visualization\\:\\ 0\\.05761352934910728\ \(0\)\
\-\ sinuses\\:\\ 0\\.05670649787840556\ \(0\)\
\-\ also\\:\\ 0\\.05663602897273241\ \(0\)\
\-\ septum\\:\\ 0\\.05658305854614101\ \(0\)\
\-\ number\\:\\ 0\\.05542211541250952\ \(0\)\
\-\ papilloma\\:\\ 0\\.055204500638995624\ \(0\)\
\-\ women\\:\\ 0\\.05417904001537638\ \(0\)\
\-\ squamous\\:\\ 0\\.05417904001537638\ \(0\)\
\-\ 44\\:\\ 0\\.05324445254312914\ \(0\)\
\-\ direct\\:\\ 0\\.05306707118120915\ \(0\)\
\-\ involves\\:\\ 0\\.05238593533387439\ \(0\)\
\-\ duct\\:\\ 0\\.05182399578407601\ \(0\)\
\-\ gray\\:\\ 0\\.05151582958159395\ \(0\)\
\-\ report\\:\\ 0\\.050712026949908784\ \(0\)\
\-\ smooth\\:\\ 0\\.04970612878341277\ \(0\)\
\-\ pregnancy\\:\\ 0\\.049267622991737606\ \(0\)\
\-\ gland\\:\\ 0\\.04890573807856447\ \(0\)\
\-\ described\\:\\ 0\\.04884661219509412\ \(0\)\
\-\ 21\\:\\ 0\\.048106679858106106\ \(0\)\
\-\ from\\:\\ 0\\.047820578431851966\ \(0\)\
\-\ considered\\:\\ 0\\.046912578760437244\ \(0\)\
\-\ typical\\:\\ 0\\.04652700373047925\ \(0\)\
\-\ cells\\:\\ 0\\.046385968991248624\ \(0\)\
\-\ diagnostic\\:\\ 0\\.045884391372148066\ \(0\)\
\-\ structures\\:\\ 0\\.04523670703489845\ \(0\)\
\-\ occur\\:\\ 0\\.044276596109833644\ \(0\)\
\-\ reported\\:\\ 0\\.04336147008989482\ \(0\)\
\-\ including\\:\\ 0\\.04308462949343331\ \(0\)\
\-\ calcification\\:\\ 0\\.04298265824030047\ \(0\)\
\-\ malignant\\:\\ 0\\.04291522067796421\ \(0\)\
\-\ extension\\:\\ 0\\.04261697325413907\ \(0\)\
\-\ biopsy\\:\\ 0\\.04220052695626332\ \(0\)\
\-\ obstruction\\:\\ 0\\.04216916306216683\ \(0\)\
\-\ 50\\:\\ 0\\.04204463132119329\ \(0\)\
\-\ was\\:\\ 0\\.04196305155594219\ \(0\)\
\-\ presentation\\:\\ 0\\.04144310428595091\ \(0\)\
\-\ 30\\:\\ 0\\.04106972860310271\ \(0\)\
\-\ masses\\:\\ 0\\.04098540903931008\ \(0\)\
\-\ thickening\\:\\ 0\\.04095745155913018\ \(0\)\
\-\ areas\\:\\ 0\\.04087402074839881\ \(0\)\
\-\ surrounding\\:\\ 0\\.04015141552513083\ \(0\)\
\-\ density\\:\\ 0\\.03992113855142227\ \(0\)\
\-\ air\\:\\ 0\\.03937852668199988\ \(0\)\
\-\ should\\:\\ 0\\.039282798655211094\ \(0\)\
\-\ superior\\:\\ 0\\.0391408152232947\ \(0\)\
\-\ between\\:\\ 0\\.0391173359197371\ \(0\)\
\-\ differential\\:\\ 0\\.0391173359197371\ \(0\)\
\-\ mr\\:\\ 0\\.03895442728680758\ \(0\)\
\-\ aspect\\:\\ 0\\.03883958455846693\ \(0\)\
\-\ frontal\\:\\ 0\\.038748601731244246\ \(0\)\
\-\ resection\\:\\ 0\\.03859124503953781\ \(0\)\
\-\ age\\:\\ 0\\.03779637129383046\ \(0\)\
\-\ carcinoma\\:\\ 0\\.036011029718670616\ \(0\)\
\-\ been\\:\\ 0\\.035075257674605946\ \(0\)\
\-\ enhancement\\:\\ 0\\.034652103074868296\ \(0\)\
\-\ cell\\:\\ 0\\.034439192113259284\ \(0\)\
\-\ evidence\\:\\ 0\\.03417161303901794\ \(0\)\
\-\ signal\\:\\ 0\\.0341276687315475\ \(0\)\
\-\ is\\:\\ 0\\.03297429068889281\ \(0\)\
\-\ bone\\:\\ 0\\.032848921655483705\ \(0\)\
\-\ bilateral\\:\\ 0\\.03235559786660988\ \(0\)\
\-\ soft\\:\\ 0\\.032051077531995015\ \(0\)\
\-\ into\\:\\ 0\\.03200315943562045\ \(0\)\
\-\ man\\:\\ 0\\.031872495562304405\ \(0\)\
\-\ without\\:\\ 0\\.03175509788244181\ \(0\)\
\-\ associated\\:\\ 0\\.031731774242902334\ \(0\)\
\-\ tissue\\:\\ 0\\.03158141416135827\ \(0\)\
\-\ other\\:\\ 0\\.03126465899007048\ \(0\)\
\-\ have\\:\\ 0\\.03007496481967809\ \(0\)\
\-\ contrast\\:\\ 0\\.029251665370549088\ \(0\)\
\-\ well\\:\\ 0\\.029150845351952018\ \(0\)\
\-\ presents\\:\\ 0\\.02896100486342284\ \(0\)\
\-\ within\\:\\ 0\\.027727888835337045\ \(0\)\
\-\ be\\:\\ 0\\.024422164767916147\ \(0\)\
\-\ ct\\:\\ 0\\.02292004859677236\ \(0\)\
\-\ are\\:\\ 0\\.022844501083087602\ \(0\)\
\-\ or\\:\\ 0\\.02094373561093229\ \(0\)\
\-\ patient\\:\\ 0\\.019581185584845315\ \(0\)\
\-\ for\\:\\ 0\\.018247227491497178\ \(0\)\
\-\ on\\:\\ 0\\.018182499029807658\ \(0\)\
\-\ to\\:\\ 0\\.015050763905075839\ \(0\)\
